We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Resmed Inc | ASX:RMD | Australian Stock Exchange | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.81 | 2.16% | 38.30 | 38.12 | 38.40 | 38.39 | 38.02 | 38.02 | 758,608 | 07:50:00 |
From Jan 2020 to Jan 2025
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2021 on Thursday, January 28, 2021, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast.
Earnings webcast details:
•
Location:
http://investor.resmed.com
•
Date:
Thursday, January 28, 2021
•
Time:
1:30 p.m. PST / 4:30 p.m. EST
•
International:
London, Thursday, January 28, 9:30 p.m. GMT
Sydney, Friday, January 29, 8:30 a.m. AEDT
Please note that ResMed does not use outside phone lines to access the earnings call.
A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from January 28 until February 11 at:
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210107005109/en/
For investors Amy Wakeham +1 858.836.5000 investorrelations@resmed.com
For media Jayme Rubenstein +1 858.836.6798 news@resmed.com
1 Year Resmed Chart |
1 Month Resmed Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
